NASDAQ:CRSP | EBITDA | CRISPR Therapeutics AG

Complete source-backed ebitda history.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$125.93M
2025-12-31-$149.1M
2025-03-31-$143.69M
2024-12-31-$59.75M
2024-03-31-$135.75M
2023-12-31$74.48M
2023-03-31-$59.44M
2022-12-31-$125.7M
2022-03-31-$169.93M
2021-12-31-$139.44M
2021-03-31-$111.83M
2020-12-31-$105.2M
2020-03-31-$71.5M
2019-12-31$12.42M
2019-03-31-$47.61M
2018-12-31-$44.28M
2018-03-31-$26.17M
2017-12-31$1.78M
2017-03-31-$20.02M
2016-12-31-$24.9M
2016-03-31-$11.55M
2015-12-31-$12.11M

Annual EBITDA

DateEBITDA
2025-12-31-$645.09M
2024-12-31-$447.31M
2023-12-31-$202.7M
2022-12-31-$648.99M
2021-12-31$391.48M
2020-12-31-$345.25M
2019-12-31$51.47M
2018-12-31-$155.42M
2017-12-31-$61.62M
2016-12-31-$67.21M
2015-12-31-$25.6M
2014-12-31-$6.59M